29.5.2024: Researchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis while sparing healthy microbes in the mouse gut. The drug, called lolamicin, also warded off secondary infections with Clostridioides difficile, a common and dangerous hospital-associated bacterial infection, and was effective against more than 130 multidrug-resistant bacterial strains in cell culture. "People are starting to realize that the antibiotics we've all been taking – that are...
7.12.2015: Currently, we solve three main tasks using Arabidopsis thaliana as model: 1. Genetic determination of metabolome pathway connected to prenylflavonoid and lupulin production in hop. 2. Study of...
14.3.2017: More than 400 decision makers and professionals attended PHARM Connect this year from over 25 countries with the same purpose: sharing their experiences, building new partnerships, finding the best...
3.5.2017: A Slovenian research institute developed protein patches applicable for healing chronic skin wounds rapidly and cost efficiently. Patches are biodegradable – disappearing in the wound, leaving no...
11.8.2014: Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech industries, Pharma-Biotech Product and Company Valuation with Dr. Patrik Frei!
Having the status of the official portal for Czech biotechnology, Gate2Biotech serves to biotechnology companies, suppliers, investors, institutions, students and general public interested in biotechnology.
The portal is dedicated to the following subjects: plant and animal ...
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Bioenergy 2007 - Conference bioenergy 2007
Biotechnology - Biotechnology channel at Nature.com
Plant non-steroidal anti-inflammatory leaves immune system intact
Meet pAblo·pCasso: A new leap in CRISPR technologies for next-gen genome engineering